Leading Product Innovator
in Interventional Neuroradiology

SITS Open stroke trial includes pREset Thrombectomy Device by phenox GmbH

phenox GmbH, announces participation in the SITS Open clinical trial where pREset and pREset LITE Thrombectomy Devices have been included in the study device portfolio, one of only three devices to be used in the study.Stroke is the second leading cause of death worldwide and the most common cause of adult disability in the western world.  Ischemic stroke, caused by a blocked artery, is the most common type of stroke and it takes only minutes without oxygen for brain damage to occur and more brain cells die every minute that flow is blocked. The aim of physicians is to restore blood flow by opening the blocked artery as quickly as possible...

continue reading

Upcoming Events


to our email news

(max. one email per month)

Hemorrhagic Stroke Treatment

Flow Diverter

Bifurcation Aneurysm Treatment

Ischemic Stroke Treatment

Thrombectomy Device



phenox GmbH
Lise-Meitner-Allee 31
D-44801 Bochum

T +49 (0) 234-36 919-0
F +49 (0) 234-36 919-19